Testing effectiveness (Phase 2)Looking for participantsNCT07641036
What this trial is testing
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
Who this might be right for
CholangiocarcinomaIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+2 more
Beijing Biotech 30